InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
0.00%
)
US TECH 100
19,249.20
(
2.08%
)
Dow Jones
41,503.10
(
0.00%
)
Brent Oil
73.77
(
1.91%
)
Bitcoin
63,113.75
(
2.34%
)
Post# of 11473
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Excalibur13

Send PM Follow Ignore
Followers 15
Posts 1500
Boards Moderated 0
Alias Born 01/22/2017

Excalibur13

Re: Ultimate Weapon post# 11194

Tuesday, 09/08/2020 6:18:36 PM

Tuesday, September 08, 2020 6:18:36 PM

Post# of 11473
Quote : approximately $102M in non-dilutive cash garnered from these two sales we will move to a zero debt position and significant cash reserve, while still retaining two attractive operating facilities. We expect that these factors would leave Emerald well-positioned to advance our existing and emerging product portfolio, and/or to acquire in a strategic and targeted manner new value-added science-based products and services with a positive business outlook focused on achieving revenue growth, profitability and value creation for our shareholders."

https://finance.yahoo.com/news/emerald-health-therapeutics-enters-share-175500105.html



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up